Buziashvili M, Davtyan H, Sereda Y, Denisiuk O, Gozalov O, Lomtadze N, et al. Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018 . Monaldi Arch Chest Dis [Internet]. 2021 Jan. 14 [cited 2024 Nov. 23];91(1). Available from: https://www.monaldi-archives.org/macd/article/view/1649